This panel discussion explores key financing pathways available to early-stage life science companies, including grants, angel investors, and venture capital. Founders will gain insight into funding trends and opportunities, focused on the current state of the biotechnology / biopharma / medical and health technology business sectors.

Save your spot to learn how life sciences startups are getting funded today and what it could mean for your next step.
 
PANELISTS:  

Margaret “Missy” Fulton

Founder & CEO, Chameleon Strategies, LLC

Margaret “Missy” Fulton is a global employment lawyer and HR leader focused on supporting life sciences startups and their leadership teams. As Founder and CEO of Chameleon Strategies, she works with founders and venture partners to align people strategy with business and scientific goals. Missy’s background includes global employment counsel, assistant attorney general, senior HR and talent leadership roles where she built programs, guided organizational growth, and helped teams navigate complex workplace challenges.

Jon Weaver

President & CEO, Massachusetts Biomedical Initiatives (MBI)

Jon Weaver is the President and CEO of Massachusetts Biomedical Initiatives (MBI), where he leads efforts to grow Central Massachusetts as a leading hub for life sciences and biomanufacturing. Under his leadership, MBI supports early-stage companies with incubation, mentorship, and access to specialized facilities that help startups progress from concept to clinical milestones.

Beyond MBI, Jon is actively engaged across the regional innovation ecosystem, serving on boards including The Venture Forum and the Center for Clinical & Translational Science at UMass Chan Medical School.

With a background spanning economic development, real estate, and nonprofit leadership, Jon is passionate about building the infrastructure, partnerships, and pathways that help founders and life sciences companies scale.

IF THIS EVENT IS CLOSED YOU MAY SIGN UP IN PERSON ON THE DAY OF EVENT